期刊文献+

聚乙二醇化生长激素释放激素的研究进展

The research of development on Pegylation of growth hormone-releasing hormone
下载PDF
导出
摘要 生长激素释放激素(growth hormone-releasing hormone,GHRH)又称生长激素释放因子(growth hormone-releasing factor,GRF),是由下丘脑分泌的一种肽类激素,具有促进垂体促生长素细胞合成和释放生长激素(growth hormone,GH)的作用,临床上可以用来治疗矮小症、HIV相关的脂肪营养不良、代谢综合征、艾滋病、创伤等疾病。然而GHRH应用到临床上的最大不足就是体内半衰期比较短(一般10~20min)。为了延长GHRH在体内的半衰期,减少频繁用药给患者带来的不适,须对GHRH进行修饰,以期达到半衰期显著延长,免疫原性有所降低。为此,本文主要综述了GHRH以及GHRH长效修饰的研究进展,尤其是PEG修饰GHRH的最新进展。 Growth hormone releasing hormone (GHRH) also known as growth hormone releasing factor (GRF), a peptide hormone, is secreted by the hypothalamus and has the function of promoting the synthesis and release of growth hormone. Although it can be used to treat short stature, HIV-associated lipodystrophy, syndrome X, AIDS, trauma and other diseases in clinic, however, the biggest shortcoming of GHRH is the short half life in vivo (usually 10-20 minutes). In order to extend the half life of GHRH in vivo, reduce the dosing frequency which bring some discomfort to the patients, some measures should be taken to modify the GHRH. This paper mainly reviews the research development of GHRH, polyethylene glycol as well as the modification of GHRH, especially the pegylation of GHRH.
出处 《中国当代医药》 2012年第14期13-15,17,共4页 China Modern Medicine
关键词 生长激素释放激素 生长激素 聚乙二醇化 修饰 Growth hormone releasing hormone Growth hormone Pegylation Modification
  • 相关文献

参考文献5

二级参考文献30

  • 1F.澳斯伯 R.E.金斯顿编著.颜子颖 王海林译.精编分子生物学试验指南[M].北京:科学出版社,1999.333-8.
  • 2Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol [ J ]. Joint Bone Spine, 2004,71 ( 6 ) : 481 - 485.
  • 3Nuki G. Treatment of crystal arthropathy--history and advances [ J]. Rheum Dis Clin North Am,2006,32 (2) :333 -357.
  • 4Brogard JM, Coumams D, Frankhauser J, et al. Enzymatic uricoly- sis : a study of the effect of a fungal urate-oxydase [ J ]. Rev Eur Etud Clin Biol, 1972,17 (9) : 890 - 895.
  • 5Schellekens H. Immunogenicity of therapeutic proteins: clinical implications and future prospects[ J ]. Clin Ther, 2002,24 (11 ) : 1 720-1 740.
  • 6Roberts M J, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation [ J ]. Adv Drug Deliver Rev ,2002 ,54 (4) : 459 - 476.
  • 7Greenwald RB, Choe YH, McGuire J, et al. Effective drug delivery by PEGylated drug conjugates [ J ]. Adv Drug Deliver Rev,2003, 55(2) :217 -250.
  • 8Veronese FM, Pasut G. PEGylation, successful approach to drug delivery [ J ]. Drug Discov Today,2005,10 ( 21 ) : 1 451 - 1 458.
  • 9Robert H, Chen L, Abuchowski A, et al. Properties of two urate oxidases modified by the covalent attachment of poly (ethylene glycol) [ J ]. Biochim Biophys Acta, 1981,660 ( 2 ) : 293 - 298.
  • 10Davis S, Park YK. Abuchowski A, et al. Hypouricaemic effect of polyethylene glycol modified urate oxidase [ J ]. Lancet, 1981,2 (8 241) :281 -283.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部